Evidence map›Paper›PMID 39131652›Full record

ReviewJournal of the Society for Cardiovascular Angiography & Interventions

Mitral Regurgitation in Female Patients: Sex Differences and Disparities.

Rebecca Ocher, Megan May, Jonathan Labin, Janki Shah, Tamara Horwich, Karol E Watson, Eric H Yang, Marcella A Calfon Press

Abstract readReview
In one paragraph

Review in Journal of the Society for Cardiovascular Angiography & Interventions. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. The Silent Cost of Gender in Mitral Valve Surgery: A Propensity-Score Matched Analysis.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2026
    Article
  4. Transcatheter mitral and tricuspid therapy: outcomes in female patients.Indian journal of thoracic and cardiovascular surgery · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rebecca OcherDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
Megan MayDivision of Cardiology, Department of Medicine, MedStar Health, Washington, DC.
Jonathan LabinDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
Janki ShahDivision of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
Tamara HorwichBarbra Streisand Women's Heart Health Program, Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
Karol E WatsonBarbra Streisand Women's Heart Health Program, Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
Eric H YangDivision of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
Marcella A Calfon PressBarbra Streisand Women's Heart Health Program, Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitral regurgitation is the most common valvular disease, particularly in older adults. Recent literature has consistently supported that there are significant differences in mitral regurgitation outcomes between male and female patients and that this is likely multifactorial. Numerous sex differences in anatomy and pathophysiology may play a role in delayed diagnoses, referrals, and treatments for female patients. Despite the recognition of these discrepancies in the literature, many guidelines that steer clinical care do not incorporate these factors into society recommendations. Identifying and validating sex-specific diagnostic parameters and increasing the representation of female patients in trials of new mitral regurgitation treatment modalities are key factors in improving outcomes for female patients.

Indexed as

mitral regurgitationtranscatheter edge-to-edge repairvalvular heart diseasewomen’s cardiovascular health

Identifiers

PMID39131652
PMCPMC11308238

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.